Targeting Homer genes using adeno-associated viral vector: lessons learned from behavioural and neurochemical studies
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Over a decade of in-vitro data support a critical role for members of the Homer family of postsynaptic scaffolding proteins in regulating the functional architecture of glutamate synapses. Earlier studies of Homer knockout mice indicated a necessary role for Homer gene products in normal mesocorticolimbic glutamate transmission and behaviours associated therewith. The advent of adeno-associated viral vectors carrying cDNA for, or short hairpin RNA against, specific Homer isoforms enabled the site-directed targeting of Homers to neurons in the brain. This approach has allowed our groups to address developmental issues associated with conventional knockout mice, to confirm active roles for distinct Homer isoforms in regulating glutamate transmission in vivo, as well as in mediating a variety of behavioural processes. This review summarizes the existing data derived from our studies using adeno-associated viral vector-mediated neuronal targeting of Homer in rodents, implicating this family of proteins in drug and alcohol addiction, learning/memory and emotional processing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Naisbitt, S., Kim, E., Tu, J. C., Xiao, B., Sala, C., Valtschanoff, J., Weinberg, R. J., Worley, P. F., & Sheng, M. (1999) · Neuron · doi:10.1016/s0896-6273(00)80809-0 · Cited by 1,009 · cited 5×
“…1998; Roche et al., 1999; Ango et al., 2000; Soloviev et al., 2000), the N-methyl-D-aspartate (NMDA) glutamate receptor scaffolding protein Shank (Naisbitt et al., 1999; Tu et al., 1999; Shiraishi et al., 2003), the inositol-1,4,5-triphosphate (IP3) receptor, a downstream mediator of group 1…”
BackgroundInfluentialTu, J. C., Xiao, B., Yuan, J. P., Lanahan, A. A., Leoffert, K., Li, M., Linden, D. J., & Worley, P. F. (1998) · Neuron · doi:10.1016/s0896-6273(00)80589-9 · Cited by 862 · cited 11×
“Homers also interact with a proline-rich sequence located on IP3Rs (Tu et al., 1998) and form mGluR/Homer/IP3R clusters in the perisynapse (Tu et al., 1998; Sala et al., 2005).”
BackgroundInfluentialBurger, C., Gorbatyuk, O. S., Velardo, M. J., Peden, C. S., Williams, P., Zolotukhin, S., Reier, P. J., Mandel, R. J., & Muzyczka, N. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.05.024 · Cited by 741
Regulation of Dendritic Spine Morphology and Synaptic Function by Shank and Homer
Sala, C., Piëch, V., Wilson, N. R., Passafaro, M., Liu, G., & Sheng, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00339-7 · Cited by 716
The Endocannabinoid System Controls Key Epileptogenic Circuits in the Hippocampus
Monory, K., Massa, F., Egertová, M., Eder, M., Blaudzun, H., Westenbroek, R., Kelsch, W., Jacob, W., Marsch, R., Ekker, M., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.07.006 · Cited by 706
Self-citationPsychomotor stimulant addiction: a neural systems perspective
Everitt, B. J., & Wolf, M. E. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03312.2002 · Cited by 700
Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission
Kalivas, P. W., Volkow, N., & Seamans, J. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.005 · Cited by 657
Quantitative analysis of the packaging capacity of recombinant adeno-associated virus
Dong, J.-Y., Fan, P.-D., & Frizzell, R. A. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.17-2101 · Cited by 583 · cited 1×
“The choice of promoter often depends upon a compromise between the levels of expression required, the target cell type and the size of the promoter that can be accommodated by the cassette without overstretching the 4.7-kb AAV packaging limit (Dong et al., 1996).”
BackgroundInfluentialSamulski, R. J., Berns, K. I., Tan, M., & Muzyczka, N. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.6.2077 · Cited by 466 · cited 1×
“AAV serotype 2 (AAV2) was the first infectious clone established in the laboratory (Samulski et al., 1982), which made this serotype the best studied and the most commonly used one to date.”
BackgroundHuman fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V., & Srivastava, A. (1999) · Nature Medicine · doi:10.1038/4758 · Cited by 443 · cited 2×
“AAV2 (Summerford and Samulski, 1998), whereas human fibroblast growth factor receptor 1 (Qing et al., 1999), aVb5 integrin (Summerford et al.”
BackgroundWoodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element
Donello, J. E., Loeb, J. E., & Hope, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.5085-5092.1998 · Cited by 350 · cited 2×
“The woodchuck posttranscriptional regulatory element is a cis-acting RNA element originating from the woodchuck hepatitits B virus, which facilitates cytoplasmic accumulation and stability of RNA (Donello et al., 1998).”
BackgroundSala, C., Futai, K., Yamamoto, K., Worley, P. F., Hayashi, Y., & Sheng, M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06327.2003 · Cited by 288 · cited 3×
“both NMDA-mediated and AMPA-mediated synaptic currents and disrupts the efficiency of group 1 mGluRmediated inhibition of ion channel activity (Sala et al., 2003; Kammermeier, 2006; Kammermeier and Worley, 2007).”
BackgroundLoeb, J. E., Cordier, W. S., Harris, M. E., Weitzman, M. D., & Hope, T. J. (1999) · Human Gene Therapy · doi:10.1089/10430349950016942 · Cited by 279 · cited 2×
“Insertion of woodchuck posttranscriptional regulatory element into an AAV cassette between the transgene and the polyadenylation signal produced 5–10-fold higher expression levels in vivo (Loeb et al., 1999; Paterna et al., 2000; Xu et al., 2001; Klein et al., 2002).”
BackgroundHepatocyte Growth Factor Receptor Is a Coreceptor for Adeno-Associated Virus Type 2 Infection
Kashiwakura, Y., Tamayose, K., Iwabuchi, K., Hirai, Y., Shimada, T., Matsumoto, K., Nakamura, T., Watanabe, M., Oshimi, K., & Daida, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.609-614.2005 · Cited by 246 · cited 1×
“Heparan sulphate proteoglycan is the primary receptor for AAV2 (Summerford and Samulski, 1998), whereas human fibroblast growth factor receptor 1 (Qing et al., 1999), aVb5 integrin (Summerford et al., 1999) and hepatocyte growth factor (Kashiwakura et al., 2005) act as coreceptors.”
BackgroundCharacterization of Adeno-Associated Virus Genomes Isolated from Human Tissues
Schnepp, B. C., Jensen, R. L., Chen, C.-L., Johnson, P. R., & Clark, K. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.23.14793-14803.2005 · Cited by 231 · cited 2×
“(1994) showed safe and efficient AAV2-mediated CNS gene transfer, AAVs have become increasingly popular in CNS gene delivery applications because of their lack of pathogenicity, neurotropism and ability to establish sustained transgene expression with very little tendency to integrate into the genome of the host cell…”
BackgroundKlein, R. L., Dayton, R. D., Tatom, J. B., Henderson, K. M., & Henning, P. P. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300331 · Cited by 196 · cited 1×
“The 1.7-kb cytomegalovirus-enhancer/chicken b-actin (CBA) promoter has been shown to facilitate a high level of AAVmediated gene expression in many brain areas (Doll et al., 1996; Kaemmerer et al., 2000; Klein et al., 2002, 2008; Broekman et al., 2006).”
BackgroundInfluentialFunctional genomics and rat models
Jacob, H. J. (1999) · Genome Research · doi:10.1101/gr.9.11.1013 · Cited by 190
Paterna, J.-C., Moccetti, T., Mura, A., Feldon, J., & Büeler, H. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301221 · Cited by 189 · cited 2×
“Insertion of woodchuck posttranscriptional regulatory element into an AAV cassette between the transgene and the polyadenylation signal produced 5–10-fold higher expression levels in vivo (Loeb et al., 1999; Paterna et al., 2000; Xu et al., 2001; Klein et al., 2002).”
BackgroundBehavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia
Szumlinski, K. K., Lominac, K. D., Kleschen, M. J., Oleson, E. B., Dehoff, M. H., Schwartz, M. K., Seeberg, P. H., Worley, P. F., & Kalivas, P. W. (2005) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2005.00120.x · Cited by 181 · cited 15×
“…objects; (iii) increased locomotor hyperactivity in response to novel environments and reduced habituation to a familiar environment; and (iv) decreased latencies to float and increased incidences of floating behaviour in a forced swim test (Szumlinski et al., 2004, 2005a; Lominac et al., 2005).”
BackgroundMethodResultInfluentialSelf-citationXu, R., Janson, C., Mastakov, M., Lawlor, P., Young, D., Mouravlev, A., Fitzsimons, H., Choi, K.-L., Ma, H., Dragunow, M., et al. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301529 · Cited by 174 · cited 5×
“AAV2 was the first AAV to be used in the brain and its pattern of transduction has been characterized in full detail (Xu et al., 2001; Burger et al., 2004).”
BackgroundInfluentialDahchour, A., De Witte, P., Bolo, N., Nédélec, J.-F., Muzet, M., Durbin, P., & Macher, J.-P. (1998) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(98)00016-x · Cited by 165 · cited 2×
“2006; Szumlinski et al., 2007; Kapasova and Szumlinski, 2008), elevates basal glutamate content in the NAC (Dahchour et al., 1998; Dahchour and De Witte, 2000; Melendez et al., 2005; Szumlinski et al., 2007; Kapasova and Szumlinski, 2008) and sensitizes the capacity of alcohol to elevate NAC…”
BackgroundRecombinant Adeno-Associated Viral Vectors in the Nervous System
Burger, C., Nash, K., & Mandel, R. J. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.781 · Cited by 110 · cited 1×
“Adeno-associated viral vector tropism in the central nervous system Different AAV serotypes target diverse cell types in the CNS because they enter cells via distinct cell surface receptors (Burger et al., 2005).”
BackgroundKlugmann, M., Leichtlein, C. B., Symes, C. W., Serikawa, T., Young, D., & During, M. J. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.01.006 · Cited by 55 · cited 14×
“When overexpressed in the hippocampus of rats, however, Homer1g enhances, whereas Homer1c does not affect Morris water maze performance (Klugmann et al., 2005b), although a recent report by Brouillette et al. (2007) reported that hippocampal Homer1c overexpression abolishes the memory-improving…”
BackgroundMethodInfluentialSelf-citation
Cited by
Synaptic depression via mGluR1 positive allosteric modulation suppresses cue-induced cocaine craving
Loweth, J. A., Scheyer, A. F., Milovanovic, M., LaCrosse, A. L., Flores-Barrera, E., Werner, C. T., Li, X., Ford, K. A., Le, T., Olive, M. F., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3590 · Cited by 157
Self-citationBell, R. L., Hauser, S. R., McClintick, J., Rahman, S., Edenberg, H. J., Szumlinski, K. K., & McBride, W. J. (2016) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.10.018 · Cited by 65
Self-citationKlugmann, M., Goepfrich, A., Friemel, C. M., & Schneider, M. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00037 · Cited by 49
Self-citationKlugmann, M., Klippenstein, V., Leweke, F. M., Spanagel, R., & Schneider, M. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001562 · Cited by 38
Self-citationde Bartolomeis, A., Iasevoli, F., Tomasetti, C., & Buonaguro, E. F. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8962-8 · Cited by 21
Metadata
- Authors
- Klugmann, M., & Szumlinski, K. K.
- Venue
- Behavioural Pharmacology
- Published
- 2008-09
- Volume
- 19
- Issue
- 5-6
- Pages
- 485-500
- ISSN
- 0955-8810 (ISSN-L)
- OpenAlex
- W2000850951
- Cited by
- 33
- References
- 23
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.